GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chemical Works of Gedeon Richter PLC (BUD:RICHTER) » Definitions » Debt-to-EBITDA
中文

Chemical Works of Gedeon Richter (BUD:RICHTER) Debt-to-EBITDA : 0.05 (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Chemical Works of Gedeon Richter Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Chemical Works of Gedeon Richter's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was Ft6,393 Mil. Chemical Works of Gedeon Richter's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was Ft18,457 Mil. Chemical Works of Gedeon Richter's annualized EBITDA for the quarter that ended in Dec. 2023 was Ft510,968 Mil. Chemical Works of Gedeon Richter's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.05.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Chemical Works of Gedeon Richter's Debt-to-EBITDA or its related term are showing as below:

BUD:RICHTER' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.05   Med: 0.14   Max: 1.04
Current: 0.05

During the past 13 years, the highest Debt-to-EBITDA Ratio of Chemical Works of Gedeon Richter was 1.04. The lowest was 0.05. And the median was 0.14.

BUD:RICHTER's Debt-to-EBITDA is ranked better than
91.82% of 660 companies
in the Drug Manufacturers industry
Industry Median: 1.665 vs BUD:RICHTER: 0.05

Chemical Works of Gedeon Richter Debt-to-EBITDA Historical Data

The historical data trend for Chemical Works of Gedeon Richter's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemical Works of Gedeon Richter Debt-to-EBITDA Chart

Chemical Works of Gedeon Richter Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.09 0.13 0.10 0.11

Chemical Works of Gedeon Richter Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.05 0.09 0.04 0.05

Competitive Comparison of Chemical Works of Gedeon Richter's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Chemical Works of Gedeon Richter's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chemical Works of Gedeon Richter's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chemical Works of Gedeon Richter's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Chemical Works of Gedeon Richter's Debt-to-EBITDA falls into.



Chemical Works of Gedeon Richter Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Chemical Works of Gedeon Richter's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(6393 + 18457) / 237688
=0.10

Chemical Works of Gedeon Richter's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(6393 + 18457) / 510968
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Chemical Works of Gedeon Richter  (BUD:RICHTER) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Chemical Works of Gedeon Richter Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Chemical Works of Gedeon Richter's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Chemical Works of Gedeon Richter (BUD:RICHTER) Business Description

Traded in Other Exchanges
Address
Gyomroi ut 19-21, Budapest, HUN, 1103
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular and central nervous system products. It manufactures medicines including original, generic and licenced products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharmaceuticals segment comprising the research and development, manufacturing, sales and marketing of pharmaceutical products, and Wholesale and Retail segment for the products of the company. The company operates internationally and the majority of its revenue is generated from the Pharmaceuticals segment.

Chemical Works of Gedeon Richter (BUD:RICHTER) Headlines

No Headlines